Navigation Links
Cardioxyl Pharmaceuticals Initiates Dose-Defining Phase IIa Study of Its Lead Candidate, CXL-1020, in Heart Failure Patients
Date:8/26/2010

or the treatment of cardiovascular disease.  Cardioxyl has developed industry-leading expertise in the chemistry, biology and clinical applications of HNO (nitroxyl) technology.  The company's core HNO platform has generated several preclinical and clinical candidates, including the company's lead compound, CXL-1020, currently in clinical development for ADHF.  Cardioxyl is a privately held company financed by life science venture investors Aurora Funds and New Enterprise Associates. (i) Heart Disease and Stroke Statistics 2009 Update. A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009; 119:e1-e161(ii) Gheorghiade, M. Reassessing treatment of acute heart failure syndromes: the ADHERE Registry. Eur Heart J Suppl.  2005  7: B13-B19(iii) Jong, P et al. Prognosis and Determinants of Survival in Patients Newly Hospitalized for Heart Failure. Arch Int Med, 2002; 162:1689-1694
'/>"/>
SOURCE Cardioxyl Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Lotus Pharmaceuticals Enter R-Bambuterol(R) Clinical Trial I
2. Jiangbo Pharmaceuticals Chairman to Ring NASDAQ Opening Bell on August 27, 2010
3. Actelion Pharmaceuticals Announces FDA Approval of Brand Name for Commercially Available VELETRI® (epoprostenol for injection) for Pulmonary Arterial Hypertension
4. China Yongxin Pharmaceuticals Reports Second Quarter 2010 Results
5. Jazz Pharmaceuticals Provides Update on FDA Advisory Committee Meeting For JZP-6 (Sodium Oxybate) in Fibromyalgia
6. Cumberland Pharmaceuticals Announces Extension of FDA Review of Acetadote® Supplemental New Drug Application
7. Shareholder Class Action Filed Against SciClone Pharmaceuticals, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
8. Optimer Pharmaceuticals Fidaxomicin Marketing Authorization Application Accepted for Review by European Medicines Agency
9. Quark Pharmaceuticals and Major Pharmaceutical Company Enter into Licensing Option Agreement for the p53 Suppressor Drug QPI-1002, the First siRNA Administered Systemically in Human
10. Biostar Pharmaceuticals, Inc. Second Quarter Revenue Increased 46.4% to $19.4 Million
11. Trubion Pharmaceuticals Inc. Reports Second-Quarter and First-Half 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... You,re visiting the dentist for what you ... or she says you need a root canal. Though ... have several questions and feel apprehensive about your upcoming ... nothing to worry about. The Pennsylvania Dental Association (PDA) ... anxiety the public may have surrounding this common procedure ...
(Date:12/19/2014)... Breckenridge Pharmaceutical, Inc. announced today that it ... Pvt. Ltd. ( Hyderabad, India ) under ... ANDAs.  Under the terms of the agreement, MSN will ... for the U.S. market, and Breckenridge will market and ... have agreed to develop an oral antibiotic with current ...
(Date:12/19/2014)... 19, 2014 In today,s increasingly global ... presence to reflect the needs of a global ... meet the needs of key stakeholders while recognizing ... According to recent research by benchmarking firm, ... participating companies averaged more than $100,000 in annual ...
Breaking Medicine Technology:Root Canals Have Become More Routine 2Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with MSN Laboratories Pvt. Ltd. 2Building a Best-in-Class Pharma Global Brand Website 2
(Date:12/19/2014)... 2014 Sub Zero Ice Cream is partnering ... drive Sunday the 28th from 2pm-6pm at the Expo Center ... in Sarasota, FL. , Inquiries regarding time slots and signing ... in the donating process, Sub Zero Ice Cream & Yogurt ... ice cream. , About Sub Zero Ice Cream & Yogurt ...
(Date:12/19/2014)... Eufaula, Oklahoma, located just 9 miles from Narconon ... lake with more than 600 miles of shoreline. ... more than 3,000 residents, hosted its annual old-fashioned holiday ... December. , Featuring Santa, Christmas lights and parade floats, ... Street. Narconon Arrowhead’s parade float participated in this ...
(Date:12/19/2014)... parents that buying an older car for their teens may put ... killed in the United States between 2008 and 2012 were driving ... important safety features that are available on newer cars, the study ... in cars at least six years old, 34 percent were in ... 11 to 15 years old, and 17 percent were in cars ...
(Date:12/19/2014)... 2014 (HealthDay News) -- Dense bunches of bacteria called biofilms ... new study finds. The researchers said these biofilms ... The presence of these biofilms may represent an increased ... to predict a person,s risk for the disease, the researchers ... these biofilms may coat the mucus layer of cells lining ...
(Date:12/19/2014)... Dennis Thompson ... News) -- Ebola,s entrance into the United States -- ... League,s mumps outbreak -- have highlighted cracks in the ... a new health policy report released Thursday. Half ... and respond to infectious disease outbreaks. That was the ...
Breaking Medicine News(10 mins):Health News:Shark Tank’s Sub Zero Ice Cream Sponsors Blood Drive 2Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 2Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 3Health News:Older Cars a Bad Choice for Younger Drivers 2Health News:Could Bacteria Play a Role in Colon Cancer? 2Health News:Most States Not Ready to Handle Infectious Disease Outbreaks: Report 2Health News:Most States Not Ready to Handle Infectious Disease Outbreaks: Report 3Health News:Most States Not Ready to Handle Infectious Disease Outbreaks: Report 4
... Researchers have for the first time cleared an important ... Neutropenia (SCN), a deadly disease characterized by a deficiency ... cell important to fighting infection and disease. A research ... in the March 14 Immunity the first evidence of ...
... total retail drug,store sales of $379 million for the four-week period ended February 28,2008, an increase of 3.2 ... 4 weeks ended February ... $379 Increase from comparable prior ... ...
... March 6, 2008 A study released this ... Healthcare System in California shows that non-polypoid colorectal neoplasms ... than previously thought and may have a greater association ... commonly diagnosed colorectal polyp. The study appears in the ...
... 6 Statement from Chuck,Mohan, executive director ... on reports of possible links between childhood ... scientific studies documenting that childhood,vaccinations cause or ... scientific research in this area. Mitochondrial diseases ...
... 6 SpectraCell Laboratories, Inc.,announced that the company ... its scientific,staff as Manager of Research & Development., ... the University of Texas,M.D. Anderson Cancer Center. He ... cellular and molecular biology research, as well as ...
... Refusing Plan Despite No Change in Payments, HARRISBURG, ... it will conduct fifteen additional informational,sessions at five locations ... Pennsylvania select the best Medicare plan and continue health,care ... continue through March 14,in King of Prussia, Exton, Blue ...
Cached Medicine News:Health News:Function of molecular switch pinpointed in severe congenital neutropenia 2Health News:Function of molecular switch pinpointed in severe congenital neutropenia 3Health News:Longs Reports Preliminary February Retail Drug Store Sales 2Health News:Colonoscopy used to identify and remove flat colon lesions 2Health News:Dr. Wei Sun, PhD, MD Joins SpectraCell Laboratories 2Health News:Meetings Set in Southeast PA to Help State Retirees Choose Best Plan to Continue Health Care Benefits 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: